Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase

PURPOSE: The aim of this study was to analyze the clinical characteristics of fatal adverse events (AEs) of rivaroxaban combined with aspirin and to underline the importance of the rational use of drugs. METHODS: The WHO global database of reported potential side effects of medicinal products (VigiB...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qingxia, Ding, Qian, Yan, Suying, Yue, Qun-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365742/
https://www.ncbi.nlm.nih.gov/pubmed/35776157
http://dx.doi.org/10.1007/s00228-022-03357-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365742/
https://www.ncbi.nlm.nih.gov/pubmed/35776157
http://dx.doi.org/10.1007/s00228-022-03357-4

Ejemplares similares